If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

GTHX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.09%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $1,947,806.42

G1 Therapeutics Insider Trading History Chart

G1 Therapeutics Share Price & Price History

^$7.91

▼ -0.19 (-2.35%)

As of 02/3/2023 01:00 AM ET

Days: 30 | 90 | 365

Cash Holders STILL Aren't Taking Steps to Prepare

From Investor Place Media | Ad

Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.

Click Here to Learn More

G1 Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/5/2023	Terry L Murdock	COO	Sell	729	$5.41	$3,943.89	36,439
1/4/2023	Andrew Perry	Insider	Sell	820	$5.58	$4,575.60	21,300
1/4/2023	Jennifer K Moses	CFO	Sell	1,639	$5.58	$9,145.62	58,549
1/3/2023	John E (Jack) Bailey, Jr.	CEO	Sell	32,019	$5.85	$187,311.15	281,889
10/18/2022	Mark A. Velleca	Director	Sell	15,000	$11.70	$175,500.00	116,000
9/20/2022	Mark A. Velleca	Director	Sell	20,000	$13.50	$270,000.00	116,000
9/13/2022	Rajesh Malik	Insider	Sell	18,000	$15.71	$282,780.00	73,207
8/16/2022	Mark A. Velleca	Director	Sell	80,000	$12.64	$1,011,200.00	116,000
7/5/2022	Terry L Murdock	COO	Sell	648	$5.17	$3,350.16	20,907
1/5/2022	James Stillman Hanson	General Counsel	Sell	1,445	$10.61	$15,331.45
1/3/2022	John E (Jack) Bailey, Jr.	CEO	Sell	34,125	$10.41	$355,241.25
7/15/2021	Mark A. Velleca	Director	Sell	10,000	$18.49	$184,900.00	71,000
7/13/2021	Mark A. Velleca	Director	Sell	10,000	$19.45	$194,500.00	71,000
6/17/2021	Mark A. Velleca	Director	Sell	10,000	$21.77	$217,700.00	71,000
6/15/2021	Mark A. Velleca	Director	Sell	10,000	$22.39	$223,900.00	71,000
5/13/2021	Mark A. Velleca	Director	Sell	30,000	$19.90	$597,000.00
5/11/2021	Mark A. Velleca	Director	Sell	10,000	$19.10	$191,000.00	51,000
4/22/2021	Rajesh Malik	Insider	Sell	15,000	$22.07	$331,050.00
4/14/2021	Mark A. Velleca	Director	Sell	10,000	$24.53	$245,300.00	51,000
3/23/2021	Rajesh Malik	Insider	Sell	15,000	$21.94	$329,100.00
2/18/2021	Mark A. Velleca	Director	Sell	10,000	$26.02	$260,200.00	52,040
2/16/2021	Mark A. Velleca	Director	Sell	11,040	$35.20	$388,608.00	52,040
1/22/2021	Rajesh Malik	Insider	Sell	15,000	$20.64	$309,600.00
1/20/2021	Mark A. Velleca	Director	Sell	10,000	$21.51	$215,100.00	47,000
12/24/2020	Seth Rudnick	Director	Sell	924	$20.10	$18,572.40
12/22/2020	Seth Rudnick	Director	Sell	18,974	$20.33	$385,741.42
12/17/2020	Mark A. Velleca	CEO	Sell	30,000	$19.53	$585,900.00	47,000
12/15/2020	Mark A. Velleca	CEO	Sell	10,000	$19.43	$194,300.00	47,000
12/10/2020	Rajesh Malik	SVP	Sell	9,000	$20.06	$180,540.00	38,200
12/10/2020	Seth Rudnick	Director	Sell	546	$20.00	$10,920.00
12/8/2020	Seth Rudnick	Director	Sell	13,161	$20.19	$265,720.59
12/1/2020	Seth Rudnick	Director	Sell	520	$20.09	$10,446.80
11/18/2020	Glenn P Muir	Director	Buy	50,000	$13.50	$675,000.00	170,969
9/4/2020	James Stillman Hanson	General Counsel	Buy	1,000	$14.95	$14,950.00	4,000

Know Your Profit Potential BEFORE You Trade!

From Tradewins | Ad

I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital.

Click here for a free copy now!

Click Here to Learn More

SEC Filings (Institutional Ownership Changes) for G1 Therapeutics (NASDAQ:GTHX)

53.13% of G1 Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

G1 Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/3/2023	Fisher Asset Management LLC	2,809,444	$15.26M	0.0%	-4.3%	6.547%
2/3/2023	Curi Wealth Management LLC	81,009	$0.44M	0.1%	+37.9%	0.189%
2/2/2023	SG Americas Securities LLC	47,047	$0.26M	0.0%	+22.6%	0.110%
2/1/2023	Bank of Montreal Can	109,339	$0.60M	0.0%	N/A	0.255%
12/8/2022	Bank of New York Mellon Corp	19,497	$0.24M	0.0%	+24.8%	0.045%
11/16/2022	Alpha DNA Investment Management LLC	42,477	$0.53M	0.4%	N/A	0.099%
11/16/2022	BNP Paribas Arbitrage SNC	42,397	$0.53M	0.0%	+1,887.7%	0.099%
11/15/2022	State Street Corp	1,618,381	$20.21M	0.0%	+1,038.1%	3.771%
11/15/2022	Jacobs Levy Equity Management Inc.	102,518	$1.28M	0.0%	-74.8%	0.239%
11/15/2022	Two Sigma Advisers LP	26,400	$0.33M	0.0%	-17.5%	0.062%
11/15/2022	Two Sigma Investments LP	262,182	$3.28M	0.0%	+134.2%	0.611%
11/15/2022	Trexquant Investment LP	67,293	$0.84M	0.0%	+270.3%	0.157%
11/15/2022	Vanguard Group Inc.	1,686,453	$21.06M	0.0%	+4.1%	3.930%
11/15/2022	Marshall Wace LLP	632,178	$7.90M	0.0%	+32.6%	1.473%
11/15/2022	Engineers Gate Manager LP	26,361	$0.33M	0.0%	+21.6%	0.061%
11/15/2022	Bank of New York Mellon Corp	19,497	$0.24M	0.0%	+24.8%	0.045%
11/15/2022	BlackRock Inc.	1,519,657	$18.98M	0.0%	+11.0%	3.541%
11/14/2022	Tudor Investment Corp Et Al	84,119	$1.05M	0.0%	+87.1%	0.196%
11/14/2022	Cubist Systematic Strategies LLC	444,841	$5.56M	0.0%	+72.5%	1.037%
11/14/2022	PDT Partners LLC	45,605	$0.57M	0.1%	-42.7%	0.106%
11/14/2022	Renaissance Technologies LLC	102,400	$1.28M	0.0%	-77.9%	0.239%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	90,139	$1.13M	0.0%	+127.3%	0.210%
11/10/2022	ExodusPoint Capital Management LP	78,938	$0.99M	0.0%	+613.2%	0.184%
11/10/2022	Dimensional Fund Advisors LP	466,430	$5.83M	0.0%	-13.3%	1.087%
11/10/2022	Tower Research Capital LLC TRC	17,404	$0.22M	0.0%	+549.4%	0.041%
11/10/2022	UBS Group AG	55,983	$0.70M	0.0%	+26,183.1%	0.130%
11/9/2022	Magnus Financial Group LLC	25,000	$0.31M	0.1%	N/A	0.058%
11/8/2022	Fisher Asset Management LLC	2,935,332	$36.66M	0.0%	+27.2%	6.841%
11/8/2022	Curi Wealth Management LLC	58,737	$0.73M	0.1%	-30.7%	0.137%
11/7/2022	Virtu Financial LLC	34,923	$0.44M	0.0%	+246.4%	0.081%
11/7/2022	Jump Financial LLC	39,500	$0.49M	0.0%	-3.8%	0.092%
11/3/2022	Barclays PLC	113,631	$1.42M	0.0%	N/A	0.266%
11/1/2022	Creative Financial Designs Inc. ADV	12,000	$0.15M	0.0%	N/A	0.028%
10/27/2022	US Bancorp DE	2,736	$34K	0.0%	N/A	0.006%
10/25/2022	Raymond James & Associates	479,635	$5.99M	0.0%	+9.5%	1.122%
10/25/2022	AE Wealth Management LLC	44,005	$0.55M	0.0%	N/A	0.103%
9/16/2022	Federated Hermes Inc.	179,472	$0.89M	0.0%	+353.2%	0.420%
8/22/2022	ExodusPoint Capital Management LP	11,068	$55K	0.0%	-57.8%	0.026%
8/18/2022	Goldman Sachs Group Inc.	340,034	$1.68M	0.0%	-23.6%	0.795%
8/17/2022	Centiva Capital LP	11,737	$58K	0.0%	N/A	0.027%
8/16/2022	Woodline Partners LP	1,797,182	$8.88M	0.1%	N/A	4.204%
8/16/2022	Price T Rowe Associates Inc. MD	47,765	$0.24M	0.0%	-72.7%	0.112%
8/16/2022	Centiva Capital LP	11,737	$58K	0.0%	N/A	0.027%
8/15/2022	State Street Corp	142,206	$0.70M	0.0%	-96.1%	0.333%
8/15/2022	PDT Partners LLC	79,537	$0.39M	0.0%	N/A	0.186%
8/15/2022	Cubist Systematic Strategies LLC	257,912	$1.27M	0.0%	+91.7%	0.603%
8/15/2022	Laurion Capital Management LP	12,656	$63K	0.0%	N/A	0.030%
8/15/2022	Millennium Management LLC	728,120	$3.60M	0.0%	+486.3%	1.703%
8/13/2022	Quantbot Technologies LP	26,287	$0.13M	0.0%	N/A	0.061%
8/13/2022	Virtu Financial LLC	10,081	$50K	0.0%	N/A	0.024%
8/13/2022	Renaissance Technologies LLC	464,000	$2.29M	0.0%	N/A	1.085%
8/13/2022	Needham Investment Management LLC	134,000	$0.66M	0.1%	-16.3%	0.313%
8/12/2022	Northern Trust Corp	91,891	$0.45M	0.0%	-76.5%	0.215%
8/12/2022	Ensign Peak Advisors Inc	25,220	$0.13M	0.0%	+225.8%	0.059%
8/12/2022	FMR LLC	488,707	$2.41M	0.0%	+0.2%	1.143%
8/11/2022	Trexquant Investment LP	18,171	$90K	0.0%	N/A	0.043%
8/11/2022	JPMorgan Chase & Co.	2,129,449	$10.52M	0.0%	+1.5%	4.981%
8/8/2022	Bay Colony Advisory Group Inc d b a Bay Colony Advisors	14,195	$0.12M	0.0%	N/A	0.033%
8/8/2022	Curi Wealth Management LLC	84,737	$0.42M	0.1%	N/A	0.198%
8/8/2022	Y Intercept Hong Kong Ltd	17,100	$84K	0.0%	N/A	0.040%
8/5/2022	Connor Clark & Lunn Investment Management Ltd.	39,658	$0.20M	0.0%	N/A	0.093%
8/3/2022	Envestnet Asset Management Inc.	10,772	$53K	0.0%	N/A	0.025%
6/30/2022	Amalgamated Bank	5,782	$44K	0.0%	N/A	0.014%
6/7/2022	Bank of America Corp DE	362,573	$2.76M	0.0%	-2.7%	0.849%
5/18/2022	BNP Paribas Arbitrage SA	3,490	$27K	0.0%	-91.1%	0.008%
5/17/2022	Beacon Pointe Advisors LLC	11,500	$87K	0.0%	N/A	0.027%
5/17/2022	Point72 Hong Kong Ltd	10,858	$83K	0.0%	N/A	0.025%
5/17/2022	Dynamic Technology Lab Private Ltd	24,187	$0.18M	0.0%	N/A	0.057%
5/16/2022	California State Teachers Retirement System	42,532	$0.32M	0.0%	-8.0%	0.100%
5/16/2022	Goldman Sachs Group Inc.	445,137	$3.38M	0.0%	+15.9%	1.042%
5/16/2022	Pinz Capital Management LP	186,515	$1.42M	0.9%	N/A	0.437%
5/16/2022	Wellington Management Group LLP	82,214	$0.62M	0.0%	-11.7%	0.193%
5/16/2022	State Street Corp	3,676,814	$27.94M	0.0%	-14.5%	8.610%
5/16/2022	Graham Capital Management L.P.	15,741	$0.12M	0.0%	N/A	0.037%
5/16/2022	Invesco Ltd.	16,108	$0.12M	0.0%	-34.7%	0.038%
5/16/2022	UBS Group AG	222,919	$1.69M	0.0%	-13.5%	0.522%
5/13/2022	Rhenman & Partners Asset Management AB	316,137	$2.40M	0.2%	-2.7%	0.740%
5/13/2022	Northern Trust Corp	390,586	$2.97M	0.0%	-4.0%	0.915%
5/13/2022	Charles Schwab Investment Management Inc.	266,345	$2.03M	0.0%	+2.2%	0.624%
5/13/2022	Federated Hermes Inc.	39,600	$0.30M	0.0%	+49.3%	0.093%
5/13/2022	Ergoteles LLC	36,200	$0.28M	0.0%	+10.5%	0.085%
5/13/2022	Vanguard Group Inc.	1,923,704	$14.62M	0.0%	-24.4%	4.504%
5/13/2022	Dimensional Fund Advisors LP	566,011	$4.30M	0.0%	+7.9%	1.325%
5/12/2022	BlackRock Inc.	3,299,849	$25.08M	0.0%	-0.3%	7.727%
5/12/2022	MetLife Investment Management LLC	23,409	$0.18M	0.0%	+56.5%	0.055%
5/12/2022	Citigroup Inc.	42,054	$0.32M	0.0%	-84.3%	0.098%
5/11/2022	Raymond James Financial Services Advisors Inc.	53,625	$0.41M	0.0%	+6.7%	0.126%
5/11/2022	Raymond James & Associates	397,879	$3.02M	0.0%	+72.0%	0.932%
5/11/2022	JPMorgan Chase & Co.	2,097,753	$15.94M	0.0%	-2.1%	4.912%
5/10/2022	ProShare Advisors LLC	11,849	$90K	0.0%	-19.1%	0.028%
5/9/2022	Swiss National Bank	70,400	$0.54M	0.0%	+9.1%	0.165%
5/9/2022	Qube Research & Technologies Ltd	16,622	$0.13M	0.0%	-47.1%	0.039%
5/5/2022	Fisher Asset Management LLC	2,311,138	$17.57M	0.0%	+1.9%	5.411%
4/29/2022	SG Americas Securities LLC	38,014	$0.29M	0.0%	-18.5%	0.089%
4/18/2022	Golden Green Inc.	12,152	$92K	0.1%	-70.7%	0.028%
4/11/2022	Nordea Investment Management AB	397,746	$3.13M	0.0%	+1.4%	0.931%
2/14/2022	Lombard Odier Asset Management Switzerland SA	1,049,947	$10.72M	0.7%	+9.2%	2.469%
2/14/2022	Virtus ETF Advisers LLC	16,088	$0.16M	0.1%	+72.2%	0.038%
2/14/2022	Needham Investment Management LLC	115,000	$1.17M	0.1%	+29.9%	0.270%
2/11/2022	Ensign Peak Advisors Inc	7,740	$79K	0.0%	N/A	0.018%

Data available starting January 2016

G1 Therapeutics, Inc. engages in the development of small molecule therapeutics for the treatment of patients with cancer. Its products pipeline includes trilaciclib, rintodestrant, and lerociclib. The company was founded by Kwok-Kin Wong and Norman E. Sharpless on May 19, 2008 and is headquartered in Research Triangle Park, NC.

Today's Range

Now: $7.91

$7.75

$8.10

50 Day Range

MA: $6.17

$5.13

$8.16

52 Week Range

Now: $7.91

$3.84

$17.49

Volume

917,415 shs

Average Volume

914,928 shs

Market Capitalization

$339.43 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.73

Who are the company insiders with the largest holdings of G1 Therapeutics?: G1 Therapeutics' top insider shareholders include:
John E (Jack) Jr Bailey (CEO)
Mark A Velleca (Director)
Rajesh Malik (Insider)
Mark A Velleca (Director)
Jennifer K Moses (CFO)
Terry L Murdock (COO)
Andrew Perry (Insider)
James S Hanson (General Counsel)
Seth Rudnick (Director)
Learn More about top insider investors at G1 Therapeutics.
Who are the major institutional investors of G1 Therapeutics?: G1 Therapeutics' top institutional investors include:
Fisher Asset Management LLC — 6.55%
Bank of Montreal Can — 0.25%
Curi Wealth Management LLC — 0.19%
SG Americas Securities LLC — 0.11%
Simplex Trading LLC — 0.00%
Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of G1 Therapeutics stock.
Which institutional investors are selling G1 Therapeutics stock?: During the last quarter, GTHX stock was sold by these institutional investors:
Fisher Asset Management LLC
Within the previous year, company insiders that have sold G1 Therapeutics company stock include:
John E (Jack) Jr Bailey (CEO)
Mark A Velleca (Director)
Rajesh Malik (Insider)
Mark A Velleca (Director)
Jennifer K Moses (CFO)
Terry L Murdock (COO)
Learn More investors selling G1 Therapeutics stock.
Which institutional investors are buying G1 Therapeutics stock?: Within the previous quarter, GTHX stock was purchased by institutional investors including:
Bank of Montreal Can
Curi Wealth Management LLC
SG Americas Securities LLC
Simplex Trading LLC